Joseph P. Lucia & Associates, LLC Novavax Inc Transaction History

Joseph P. Lucia & Associates, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Apr 19, 2022	BUY	$69.73 - $142.9 $3,904 - $8,002	56 New	56 $4,000
Q4 2021 Feb 04, 2022	SELL	$134.56 - $217.97 $7,535 - $12,206	-56 Closed	0 $0
Q4 2020 Jan 29, 2021	BUY	$78.74 - $139.5 $4,409 - $7,812	56 New	56 $6,000
Q3 2020 Oct 20, 2020	SELL	$79.44 - $178.51 $3,972 - $8,925	-50 Closed	0 $0
Q1 2020 Apr 22, 2020	BUY	$3.93 - $16.0 $196 - $800	50 New	50 $1,000

291

93.4M

6.95M

9.4M

Ticker NVAX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 78,215,104
Market Cap $674M
Description
Novavax, Inc., a biotechnology company, focuses on the discovery, development, and commercialization of vaccines to prevent serious infectious diseases and address health needs. The company's vaccine candidates include NVX-CoV2373, a coronavirus vaccine candidate that is in two Phase III trials, one Phase IIb trial, and one Phase I/II trial; Nan...

Get notified when there are updates to the investment portfolio of Joseph P. Lucia & Associates, LLC, based on Form 13F filings with the SEC.

Stay updated on Joseph P. Lucia & Associates, LLC with notifications on news.